Initial empirical antimicrobial therapy: Duration and subsequent modifications

Clinical Infectious Diseases

Volumn 39, Issue SUPPL. 1, 2004, Pages

  Tamura, K ^a,b  

^a FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; CIPROFLOXACIN; LEVOFLOXACIN; TEICOPLANIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; CONFERENCE PAPER; FEBRILE NEUTROPENIA; GRAM POSITIVE BACTERIUM; HIGH RISK PATIENT; HUMAN; INFECTION COMPLICATION; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MUCOSA INFLAMMATION; PERSISTENT INFECTION; PRIORITY JOURNAL; SKIN DEFECT;

ALGORITHMS; ANTI-BACTERIAL AGENTS; COLONY-STIMULATING FACTORS; DRUG THERAPY, COMBINATION; FEVER; GAMMA-GLOBULINS; HUMANS; IMMUNOCOMPROMISED HOST; JAPAN; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RISK ASSESSMENT; SEPSIS;

EID: 3242788623     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383057     Document Type: Conference Paper

References (6)

1. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
2. Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Disease Society of America. Clin Infect Dis 1997; 25:551-73.
3. Tamura K, Imajo K, Akiyama N, et al. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. Clin Infect Dis 2004; 39(suppl 1):S15-24.
4. Tamura K, Matsuoka H, Tsukada J, et al. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycoside: comparative study. Am J Hematol 2002; 71:248-55.
5. Yoshida M, Tsubaki K, Kobayashi T, et al. Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991. Int J Hematol 1999; 70:261-7.
6. Masaoka T. Combination therapy of antibiotics and intravenous immunoglobulin [in Japanese]. Nippon Rinsho 2001; 59:781-4.